Localization of Myocardial Amyloid Deposits in Cardiac Amyloidosis by Tc-99m Pyrophosphate Myocardial SPECT: Implication for Medical Treatment
Authors:
- Danielle Casset-SenonDCDanielle Casset-Senon
- Véronique SecchiVSVéronique Secchi
- Philippe ArbeillePAPhilippe Arbeille
- Pierre CosnayPCPierre Cosnay
- 1 July 2005
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 30 (7) , 496-497
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Angina with a normal coronary angiogram caused by amyloidosis: Figure 1Heart, 2004
- Myocardial Tc-99m MDP Uptake on a Bone Scan in Senile Systemic Amyloidosis with Cardiac InvolvementClinical Nuclear Medicine, 2000
- Tc-99m HDP Uptake in Cardiac AmyloidosisClinical Nuclear Medicine, 1999
- Soft-tissue uptake of99m-Tc-diphosphonate and99mTc-pyrophosphate in amyloidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: A study with familial amyloid polyneuropathyAmerican Heart Journal, 1987
- Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agentsThe American Journal of Cardiology, 1985
- Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosisThe American Journal of Cardiology, 1983
- Diagnostic considerations in cardiomyopathy: Unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart diseaseAmerican Heart Journal, 1982
- Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosisAmerican Heart Journal, 1982